Natco Pharma Ltd share price logo

Natco Pharma Share Price (NATCOPHARM)

Check the latest share price of Natco Pharma, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹961.83.66%

as on 04:01PM, 11 Jul 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Natco Pharma Stock Performance

Get live Natco Pharma share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹960.1
    Day's Price Range
    ₹997.05
  • 52 Week's Low

    52 Week's High

    ₹726.8
    52-Week Price Range
    ₹1,639
1 Month Return+ 6.87 %
3 Month Return+ 28.73 %
1 Year Return-15.84 %
3 Year Return+ 57.24 %
5 Year Return+ 47.01 %
Previous Close₹998.30
Open₹991.10
Volume13.55L
Upper Circuit₹1,197.95
Lower Circuit₹798.65

Natco Pharma Fundamentals & Key Indicators

Check Natco Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹17,880.54 Cr

Return on Equity (ROE)

25.38

PE Ratio (TTM)

9.48

Return on capital employed (ROCE)

28.58

Industry PE ratio

51.93

Beta (LTM)

0.81

P/B Ratio

3.05

Dividend Yield

1

PEG Ratio

0.34

Quarterly Earnings Growth YOY

5.1

EPS (TTM)

77.56

Sector

Pharmaceuticals

Book Value

326.99

Technical Analysis

How to invest in Natco Pharma?

Investing in Natco Pharma is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Natco Pharma or NATCOPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Natco Pharma or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Natco Pharma with just a few clicks!

Natco Pharma Stock's Interest Amongst Investors

20.66%

Period Jul 12, 2025 to Jun 12, 2025. Change in 30 Days vs previous period

Investment in Natco Pharma Ltd Shares on INDmoney has grown by 20.66% over the past 30 days, indicating increased transactional activity.

47%

Period Jul 12, 2025 to Jun 12, 2025. Change in 30 Days vs previous period

Search interest for Natco Pharma Ltd Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.

Natco Pharma Valuation

Track how Natco Pharma P/E has moved over time to understand its valuation trends.

Natco Pharma in the last 5 years

  • Overview

  • Trends

Lowest (7.09x)

April 9, 2025

Today (9.48x)

July 10, 2025

Industry (51.93x)

July 10, 2025

Highest (90.32x)

April 6, 2022

LowHigh

Today’s Price to Earnings Ratio: 9.48x

Natco Pharma Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Natco Pharma.

based on 11 analysts

HOLD

30.00%

Buy

30.00%

Hold

40.00%

Sell

40% of analysts recommend a 'HOLD' rating for Natco Pharma. Average target price of ₹967.45

Source: S&P Global Market Intelligence

Natco Pharma Share Price Target

Get share price movements and forecasts by analysts on Natco Pharma.

Natco Pharma price forecast by 11 analysts

Downside of-3.09%

High

₹1480

Target

₹967.45

Low

₹697

Natco Pharma target price ₹967.45, a slight downside of -3.09% compared to current price of ₹961.8. According to 11 analysts rating.

Source: S&P Global Market Intelligence

Natco Pharma Financial Results

Get the annual and quarterly financial summary of Natco Pharma, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

1068 (0%)1363 (28%)1371 (1%)475 (65%)1221 (157%)
Net Income

(in ₹ Cr)

386 (0%)668 (73%)676 (1%)132 (80%)406 (207%)
Net Profit Margin36.16% (0%)49.06% (36%)49.34% (1%)27.89% (43%)33.25% (19%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

4817 (0%)5106 (6%)5564 (9%)6763 (22%)
Total Liabilities

(in ₹ Cr)

726 (0%)914 (26%)862 (6%)1170 (36%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

422 (0%)184 (57%)58 (69%)784 (1259%)1196 (53%)

Indices Featuring Natco Pharma Stock

Check stock indices that include Natco Pharma.

S&P BSE SmallCap Select

₹8,152.49

-1.16 (-95.29%)

Nifty Smallcap 250

₹17,645.45

-0.7 (-125.2%)

S&P BSE 400 MidSmallCap

₹12,211.26

-0.72 (-88.16%)

BSE 500

₹36,545.58

-0.8 (-293.17%)

Nifty MidSmallcap 400

₹20,232.00

-0.79 (-160.6%)

Nifty Small 100

₹18,763.45

-1.02 (-192.8%)

NIFTY PHARMA

₹22,225.90

0.68 (149.1%)

Nifty 500

₹23,282.70

-0.8 (-188.7%)

S&P BSE 250 SmallCap

₹7,040.70

-0.65 (-45.85%)

BSE Small-Cap

₹54,484.76

-0.7 (-383.93%)

BSE Healthcare

₹44,329.97

0.17 (73.87%)

Nifty Smallcap 50

₹9,061.30

-1.04 (-95.2%)

Natco Pharma Earnings and Dividends

View detailed summary of the earnings and dividend history of Natco Pharma.

  • Natco Pharma Ltd Earnings Results

    Natco Pharma Ltd’s net profit jumped 5.25% since last year same period to ₹406.60Cr in the Q4 2024-2025. On a quarterly growth basis, Natco Pharma Ltd has generated 205.71% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Natco Pharma Ltd Dividends February,2025

    In the quarter ending December 2024, Natco Pharma Ltd has declared dividend of ₹1.50 - translating a dividend yield of 0.73%.

    Read More about Dividends

Natco Pharma Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Natco Pharma.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
49.56%
0.00
Foreign Institutions
17.49%
0.00
Mutual Funds
1.85%
0.00
Retail Investors
27.29%
0.00
Others
3.8%
0.00

Natco Pharma vs Peers

Compare market cap, revenue, PE, and other key metrics of Natco Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
HOLD17,880.549.4%0.541,3883,998
BUY13,812.24-4.25%0.524132,013
BUY66,205.207.92%0.563,16829,001
HOLD97,901.5434.34%0.643,85419,547
BUY73,429.3824.61%0.53NANA

Natco Pharma News & Key Events

Latest news and events in one place to help you make informed investing decisions in Natco Pharma.

  • Natco Pharma Shows Bullish Momentum at ₹890 Level - 04 Jul, 2025

    Natco Pharma has found support near ₹890, with buyers pushing the stock to ₹973. The stock shows bullish momentum, closing above key EMAs, with increasing volume and positive RSI. Accumulation is recommended on dips towards ₹912, targeting ₹1,140–₹1,200.
  • Natco Pharma Shows Strong Upside Potential - 03 Jul, 2025

    Natco Pharma is experiencing increased trading volume and positive momentum, indicating a potential breakout. Analysts suggest a target price of ₹1,010 with a stoploss at ₹925.
  • Natco Pharma Leads Nifty Pharma Rally - 30 Jun, 2025

    On June 30, 2025, Natco Pharma Ltd's share price rose over 4%, contributing to a 0.68% increase in the Nifty Pharma index. The company's market capitalization stands at Rs 15,841.37, reflecting mixed performance reviews that supported its upward movement on the NSE.
  • Natco Pharma Faces FDA Observations in Hyderabad - 19 Jun, 2025

    Natco Pharma's Hyderabad division received seven observations from the FDA following an inspection. The company is confident in addressing these issues while maintaining compliance with cGMP standards.
  • Natco Pharma Receives USFDA Observation at API Unit - 13 Jun, 2025

    Natco Pharma's Mekaguda API manufacturing facility received one procedural observation from the USFDA following an inspection. The company is committed to addressing the observation comprehensively.
  • Natco Pharma Gains for Third Consecutive Session - 11 Jun, 2025

    Natco Pharma Ltd has gained 3.01% today, marking its third consecutive session of increases. The stock is currently priced at Rs 908.15, despite being down 22.31% over the past year. In the last month, it has risen approximately 8.92%. The Nifty Pharma index has also shown positive movement, up 4.53% in the same period.
  • Natco Pharma Reports Strong Q4 Results for March 2025 - 05 Jun, 2025

    Natco Pharma's standalone net sales for March 2025 reached Rs 1,157.40 crore, up 19.96% YoY. Net profit rose 22.63% to Rs 428.10 crore, with EBITDA increasing 27.57%. However, shares have declined 39.96% over the last six months.

Insights on Natco Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 26.87% to 27.29% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 651.1 Cr → 1.28K Cr (in ₹), with an average increase of 49.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 133.0 Cr → 406.6 Cr (in ₹), with an average increase of 67.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, NATCOPHARM stock has moved up by 28.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 49.4% return, outperforming this stock by 65.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.0% return, outperforming this stock by 67.8%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 17.94% to 17.49% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 49.62% to 49.56% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.92% to 1.85% in Mar 2025 quarter

About Natco Pharma

Natco Pharma Limited is an international, RD focused pharmaceutical company that specialises in the development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). Natco sells products in over 40 countries, and provides contract manufacturing services for other pharmaceutical companies. The company was originally founded in 1981, and has since enjoyed significant growth, launching a variety of products and earning a number of milestones such as a compulsory license from Bayer for its patent protected anticancer drug Nexavar in 2012, and various first-to-market generic drugs including HEPCINAT (generic Sofosbuvir) and Epclusa (a single tablet regimen for the treatment of genotypes 2 and 3 chronic hepatitis C virus HCV infection). In 2021, Natco had 8 launches in the domestic market and acquired Dash Pharmaceuticals LLC in the US. Natco has 8 international subsidiaries, including the Philippines, Australia, Brazil and the US, constantly achieving the first generic to market for a variety of drugs. Natco's ambition for growth looks set to continue in 2022, with a number of new launches planned.

Revenue: ₹1,221.00Cr as on March 2025 (Q4 FY25)
Net Profit: ₹406.00Cr as on March 2025 (Q4 FY25)
Listing date: 27 Dec, 1995
Chairperson Name: G S Murthy
OrganisationNatco Pharma Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOG S Murthy
E-voting on sharesClick here to vote

Mutual Funds that own Natco Pharma

Check out the Mutual Funds with significant holdings in Natco Pharma.

FAQs

What is Natco Pharma share price today?

Natco Pharma share price today stands at ₹961.8, Open: ₹991.1, Previous Close: ₹998.3, High: ₹997.05, Low: ₹960.1, 52 Week High: ₹1639, 52 Week Low: ₹726.8.

What is today's traded volume of Natco Pharma?

Today's traded volume of Natco Pharma is 13.55L. Which means that 13.55L shares of Natco Pharma were bought and sold on the stock market during today's trading session.

What is Natco Pharma's market cap today?

Today's market capitalisation of Natco Pharma is ₹17,880.54 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Natco Pharma?

Natco Pharma’s 52 week high is ₹1639 and 52 week low is ₹726.8. The current share price of Natco Pharma is ₹961.8, which is -41.32% down from its 52 week high and 32.33% up from its 52 week low.